Tel Aviv - Delayed Quote ILA

InterCure Ltd. (INCR.TA)

581.80

-13.20

(-2.22%)

At close: 5:24:12 PM GMT+3

InterCure Announces FY2024 Results and Provides Q1 2025 Update: Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million, Strong Start to 2025

InterCure Ltd. (Nasdaq: INCR) (TASE: INCR) ("InterCure" or the "Company") today announced results for the full year ended December 31, 2024. All amounts are expressed in New Israeli Shekels (NIS), unless otherwise noted.

PR Newswire 5 days ago

INCR
InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak

InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), announces today that Mr. Ehud Barak will step down as Chairman of the board of directors of the Company (the "Board"), effective February 13, 2025. He will be succeeded by Mr. Alexander Rabinovich, who has successfully led the Company as CEO for the past five years, executing hundreds of percentages of profitable growth, building strategic international partnerships, and establishing InterCure's position as

PR Newswire 2 months ago

INCR
InterCure has Secured Funding of NIS 66M to support the recovery of Nir Oz Facility

InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), is pleased to announce that further to the Company's prior reports regarding the war-related damages and the reconstruction efforts of its facility in Kibbutz Nir Oz, the Company was successful in obtaining funding commitments of NIS 66 million (approximately USD 18.2M), which may increase to NIS 107 million (approximately USD 29.8M).

PR Newswire 4 months ago

INCR
Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Key Takeaways; Cannabis Sector SNDL acquired Indiva in efforts to strengthen position in cannabis edibles market. Ascend Wellness overhauled leadership amid financial struggles. Avicanna reduced debt with $2M private placement funds. InterCure reported a break-even first half of 2024 despite Israel-Hamas war disruptions. Key Takeaways; Psychedelic Sector Awakn announced a breakthrough in aminoindane pre-clinical program. […]

Market Exclusive 7 months ago

SNDL

AWKNF

INCR
InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million

Revenues during the first half of 2024 reached NIS 126 million, alongside an Adjusted EBITDA1of NIS 21 million (Approximately 17% of revenues).Both quarters (Q1 and Q2 of 2024) ended with positive EBITDAs and profit from operations and represents InterCure’s 16th and 17th consecutive quarter of profitability2.Revenues for the first half of 2024 were affected by damages caused by the terrorist attack on October 7, 2023, and the war in Gaza. InterCure is entitled to full compensation from the Isra

GlobeNewswire 8 months ago

INCR
InterCure Announces Expansion of its Strategic partnership with Cookies to Germany

NEW YORK & HERZLIYA, Israel, August 28, 2024--InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading vertically integrated medical cannabis company outside of North America, is announcing a new strategic agreement with Cookies, the globally recognized cannabis brand, to cultivate, manufacture, import and distribute Cookies’ branded products, produced from its cultivation and manufacturing facilities, initially in 8 licensed branded pharmacies across

Business Wire 8 months ago

INCR
InterCure to Participate in Canaccord Genuity’s 8th Annual Global Cannabis Conference

NEW YORK & HERZLIYA, Israel, May 22, 2024--InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc), the leading medical cannabis company outside of North America, today announced that it will participate in the Canaccord Genuity 8th Annual Global Cannabis Conference. The conference is scheduled for tomorrow, May 23, 2024, at the Westin NY Grand Central Hotel in New York City.

Business Wire 11 months ago

INCR

Performance Overview

Return	INCR.TA	S&P 500 (^GSPC)
YTD	-2.02%	-4.39%
1-Year	-52.12%	+8.40%
3-Year	-69.44%	+36.38%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

InterCure Ltd. (INCR.TA)

InterCure Announces FY2024 Results and Provides Q1 2025 Update: Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million, Strong Start to 2025

InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak

InterCure has Secured Funding of NIS 66M to support the recovery of Nir Oz Facility

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million

InterCure Announces Expansion of its Strategic partnership with Cookies to Germany

InterCure to Participate in Canaccord Genuity’s 8th Annual Global Cannabis Conference

Performance Overview